These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27699241)

  • 21. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
    Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
    BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic
    Guo J; Sun X; Yin H; Wang T; Li Y; Zhou C; Zhou H; He S; Cong H
    Front Cell Infect Microbiol; 2018; 8():163. PubMed ID: 29876322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
    Khan IA; Casciotti L
    J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
    Kim S; Li L; McMurtrey CP; Hildebrand WH; Weidanz JA; Gillanders WE; Diamond MS; Hansen TH
    J Immunol; 2010 Apr; 184(8):4423-30. PubMed ID: 20212098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16.
    Wang LJ; Xiao T; Xu C; Li J; Liu GZ; Yin K; Cui Y; Wei QK; Huang BC; Sun H
    Vaccine; 2018 Jun; 36(27):3943-3948. PubMed ID: 29793893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
    Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
    Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of Immune Responses Elicited by Adjuvanted Tachyzoite Lysate Vaccines Developed from Two Different Toxoplasma gondii Strains Isolated in Turkey].
    Polat C; Gülçe İz S; Döşkaya M; Can H; Caner A; Değirmenci A; Balcan E; Gürüz Y
    Mikrobiyol Bul; 2013 Jan; 47(1):122-34. PubMed ID: 23390909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery.
    Alexander J; Oseroff C; Dahlberg C; Qin M; Ishioka G; Beebe M; Fikes J; Newman M; Chesnut RW; Morton PA; Fok K; Appella E; Sette A
    J Immunol; 2002 Jun; 168(12):6189-98. PubMed ID: 12055232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.
    Roozbehani M; Falak R; Mohammadi M; Hemphill A; Razmjou E; Meamar AR; Masoori L; Khoshmirsafa M; Moradi M; Gharavi MJ
    Vaccine; 2018 Oct; 36(41):6124-6132. PubMed ID: 30181047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
    Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
    Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.
    Liu Y; Cao A; Li Y; Li X; Cong H; He S; Zhou H
    BMC Infect Dis; 2017 Jun; 17(1):403. PubMed ID: 28592247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii.
    Cong H; Gu QM; Yin HE; Wang JW; Zhao QL; Zhou HY; Li Y; Zhang JQ
    Vaccine; 2008 Jul; 26(31):3913-21. PubMed ID: 18555564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
    Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C57BL/6 mice immunized with synthetic peptides from Toxoplasma gondii surface and microneme immunodominant antigens are able to decrease parasite burden in the brain tissues.
    Barros HLS; Santana SS; Pajuaba ACAM; da Silva Cardoso Barros P; Dos Reis de Carvalho F; de Paiva VF; Wilson Patriarca Mineo T; Mineo JR
    Acta Trop; 2019 Aug; 196():1-6. PubMed ID: 31059707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
    Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
    J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Unusual MHC Molecule Generates Protective CD8+ T Cell Responses to Chronic Infection.
    Tsitsiklis A; Bangs DJ; Lutes LK; Chan SW; Geiger KM; Modzelewski AJ; Labarta-Bajo L; Wang Y; Zuniga EI; Dai S; Robey EA
    Front Immunol; 2020; 11():1464. PubMed ID: 32733483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico and in vivo analysis of Toxoplasma gondii epitopes by correlating survival data with peptide-MHC-I binding affinities.
    Huang SY; Jensen MR; Rosenberg CA; Zhu XQ; Petersen E; Vorup-Jensen T
    Int J Infect Dis; 2016 Jul; 48():14-9. PubMed ID: 27109108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
    Reiser M; Wieland A; Plachter B; Mertens T; Greiner J; Schirmbeck R
    J Immunol; 2011 Sep; 187(5):2172-80. PubMed ID: 21810614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.